Connection
Douglas Fish to Fluoroquinolones
This is a "connection" page, showing publications Douglas Fish has written about Fluoroquinolones.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.831 |
|
|
|
-
Fish DN. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit. Int J Antimicrob Agents. 2007 Jun; 29(6):715-23.
Score: 0.287
-
Fish DN, North DS. Gatifloxacin, an advanced 8-methoxy fluoroquinolone. Pharmacotherapy. 2001 Jan; 21(1):35-59.
Score: 0.186
-
Olsen KM, Rebuck JA, Weidenbach T, Fish DN. Pharmacokinetics of intravenous trovafloxacin in critically ill adults. Pharmacotherapy. 2000 Apr; 20(4):400-4.
Score: 0.176
-
Jung R, Husain M, Choi MK, Fish DN. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2004 Mar; 48(3):1055-7.
Score: 0.058
-
Fish DN. Fluoroquinolone adverse effects and drug interactions. Pharmacotherapy. 2001 Oct; 21(10 Pt 2):253S-272S.
Score: 0.049
-
Bertino J, Fish D. The safety profile of the fluoroquinolones. Clin Ther. 2000 Jul; 22(7):798-817; discussion 797.
Score: 0.045
-
Fish DN, Piscitelli SC, Danziger LH. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy. 1995 May-Jun; 15(3):279-91.
Score: 0.031